Quest DiagnosticsvsMerck & Company

DGX and MRK stock compared: price, dividend, valuation and results, from SEC filings.

DGX

Quest Diagnostics Incorporated

$259.96

Value $28.6B

+1.41%
DGX's page

MRK

Merck & Company, Inc.

$139.11

Value $344B

-2.96%
MRK's page

Quest Diagnostics (DGX) has a market value of $28.6B and Merck & Company (MRK) $344B. Over the last year, with dividends, DGX moved +42.0% and MRK +54.2%. The P/E is 25.3 for DGX and 140.2 for MRK. Dividend yield: DGX 1.30%, MRK 2.44%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    DGX$28.6B

    MRK$344B

    MRK is 12 times DGX

  • Revenue, 12 months

    DGX$11.8B

    MRK$67.4B

    MRK is 5.7 times DGX

  • Net income, 12 months

    DGX$1.1B

    MRK$2.5B

    MRK is 2.2 times DGX

  • Operating margin

    DGX14.5%

    MRK–

  • ROIC

    DGX10.2%

    MRK3.9%

    6.3 points apart

  • P/E

    DGX25.3

    MRK140.2

    MRK is 5.5 times DGX

  • Dividend yield

    DGX1.3%

    MRK2.4%

    1.1 points apart

  • 5-year return

    DGX+93.7%

    MRK+96.2%

    2.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

DGX+93.7%

MRK+96.2%

10015020020222023202420252026
Returns by period
PeriodDGXWith dividendsMRKWith dividends
1 year since November 17, 2025+42.0%Price +39.6%+54.2%Price +49.8%
3 years since November 17, 2023+104.0%+26.8% a yearPrice +92.7%+49.9%+14.4% a yearPrice +36.7%
5 years since November 17, 2021+93.7%+14.1% a yearPrice +75.9%+96.2%+14.4% a yearPrice +68.4%
10 years since November 18, 2016+269.8%+14.0% a yearPrice +203.9%+219.7%+12.3% a yearPrice +135.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

DGXQuest DiagnosticsMRKMerck & Company

Valuation

DGXMRK
Valuation
Price$259.96$139.11
Market value$28.6B$344B
Enterprise value (EV)$33.3B$388B
P/E25.3140.2
P/E, 5-year median19.614.8
P/B3.77.7
EV/EBIT19.381.5
Free cash flow yield4.8%4.3%

Results and growth

DGXMRK
Results and growth
Revenue, 12 months$11.8B$67.4B
Net income, 12 months$1.1B$2.5B
Free cash flow, 12 months$1.4B$14.7B
Earnings per share, 12 months$10.04$0.98
Revenue growth, year on year11.8%1.3%
Revenue growth a year, past+3.2%over 5 years+9.4%over 5 years
EPS growth a year, past-3.5%over 5 years+21.2%over 5 years

Margins and returns on capital

DGXMRK
Margins and returns on capital
Gross margin33.1%71.8%
Operating margin14.5%–
Net margin9.5%3.6%
ROIC10.2%3.9%
ROE15.3%5.2%

Balance sheet

DGXMRK
Balance sheet
Cash$797M$9.7B
Total debt$6.3B$53.8B
Net debt / EBITDA2.15.7
Interest cover–2.4×

Dividends and buybacks

DGXMRK
Dividends and buybacks
Dividend yield1.3%2.4%
Dividend per share, 12 months$3.38$3.40
Dividend growth a year, past+7.5%over 5 years+5.8%over 5 years
Buyback yield1.6%1.5%
Shareholder yield2.9%3.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: DGX or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Quest Diagnostics or Merck & Company?

By market value, Merck & Company ($344B) is about 12.0 times Quest Diagnostics ($28.6B), at today's prices.

How did DGX and MRK stock do over the last 10 years?

Since November 18, 2016, DGX's price moved +203.9% and MRK's +135.7%. With dividends: DGX +269.8% (+14.0% a year), MRK +219.7% (+12.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, DGX or MRK?

The dividend yield at today's price is 1.30% for Quest Diagnostics and 2.44% for Merck & Company. Over the last twelve months they paid $3.38 and $3.40 per share.

What is the P/E of DGX and MRK?

At today's price, the P/E is 25.3 for DGX and 140.2 for MRK. The median of the last five years was 19.6 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Quest Diagnostics or Merck & Company?

Over the last twelve months, the net margin was 9.5% for Quest Diagnostics and 3.6% for Merck & Company, and the operating margin 14.5% and –. Revenue was $11.8B and $67.4B.

Which is the better investment, Quest Diagnostics or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.